Acurx Pharmaceuticals Inc... (ACXP)
NASDAQ: ACXP
· Real-Time Price · USD
5.11
0.25 (5.14%)
At close: Aug 15, 2025, 3:59 PM
5.12
0.20%
After-hours: Aug 15, 2025, 05:58 PM EDT
Acurx Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -2.27M | -2.15M | -2.78M | -2.82M | -4.12M | -4.38M | -5.12M | -3.12M | -3.44M | -2.9M | -3.26M | -3.54M | -2.62M | -2.67M | -2.63M | -4.64M | -4.07M | -1.47M |
Interest Income | 23.4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -2.25M | -2.15M | -2.78M | -2.82M | -4.12M | -4.38M | -5.12M | -3.12M | -3.44M | -2.9M | -3.26M | -3.54M | -2.62M | -2.67M | -2.63M | -4.64M | -4M | -1.47M |
Net Income | -2.25B | -2.15M | -2.78M | -2.82M | -4.12M | -4.38M | -5.12M | -3.12M | -3.44M | -2.9M | -3.26M | -3.54M | -2.62M | -2.67M | -2.63M | -4.64M | -4M | -1.47M |
Selling & General & Admin | 1.75B | 1.55M | 1.96M | 1.62M | 2.3M | 2.82M | 3.17M | 1.77M | 1.71M | 1.89M | 1.83M | 1.95M | 1.71M | 1.85M | 1.91M | 3.52M | 3.98M | 1.38M |
Research & Development | 524.21M | 598.8K | 825.06K | 1.2M | 1.83M | 1.55M | 1.94M | 1.35M | 1.74M | 1.02M | 1.43M | 1.59M | 911.69K | 818.89K | 716.22K | 1.13M | 95.07K | 91.91K |
Other Expenses | -2.27B | 202.00 | -59 | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.27M | 2.15M | 2.78M | 2.82M | 4.12M | 4.38M | 5.12M | 3.12M | 3.44M | 2.9M | 3.26M | 3.54M | 2.62M | 2.67M | 2.63M | 4.64M | 4.07M | 1.47M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.2M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.27M | 2.15M | 2.78M | 2.82M | 4.12M | 4.38M | 5.12M | 3.12M | 3.44M | 2.9M | 3.26M | 3.54M | 2.62M | 2.67M | 2.63M | 4.64M | 4.07M | 1.47M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -5.11K | -3.12K | n/a | -2.9K | n/a | -3.55K | -2.62K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.19M | 1M | 851.55K | 818.15K | 791.25K | 773.65K | 673.1K | 650.25K | 609.3K | 581.95K | 580.3K | 557.4K | 513.15K | 511.65K | 511.23K | 505.8K | 348.4K | 477.05K |
Shares Outstanding (Diluted) | 1.19M | 1M | 851.55K | 818.15K | 791.25K | 773.65K | 673.1K | 650.25K | 609.3K | 581.95K | 580.3K | 557.4K | 513.15K | 511.65K | 511.23K | 505.8K | 348.4K | 477.05K |
EPS (Basic) | -1.89 | -2.14 | -3.27 | -3.45 | -5.21 | -5.66 | -7.6 | -4.79 | -5.6 | -5 | 3.60 | -6.4 | -5.2 | -5.2 | -5.2 | -9.2 | -11.4 | -3 |
EPS (Diluted) | -1.89 | -2.14 | -3.27 | -3.45 | -5.21 | -5.66 | -7.6 | -4.79 | -5.6 | -5 | 3.60 | -6.4 | -5.2 | -5.2 | -7.6 | -9.2 | -11.4 | -3 |
EBITDA | -2.25M | -2.15M | -2.78M | -2.82M | -4.12M | -4.38M | -5.12M | -3.12M | -3.44M | -2.9M | -3.26M | -3.54M | -2.62M | -2.67M | -2.63M | -4.64M | n/a | -1.47M |
EBIT | -2.25M | -2.15M | -2.78M | -2.82M | -4.12M | -4.38M | -5.12M | -3.12M | -3.44M | -2.9M | -3.26M | -3.54M | -2.62M | -2.67M | -2.63M | -4.64M | -4.07M | -1.47M |
Depreciation & Amortization | n/a | n/a | n/a | 2.82M | 4.12M | 4.38M | n/a | 3.12M | 3.44M | 2.9M | 3.26M | n/a | n/a | 2.67M | -66.5K | 4.64M | 4.07M | 1.47M |